Global Medicare · Ovarian Program
An additional specialist assessment before deciding on the next fertility step
A structured evaluation pathway for women seeking another review of ovarian-factor fertility concerns, including low ovarian reserve, poor ovarian response, previous unsuccessful IVF or advanced reproductive age.Start with your situation
When an additional review may be useful
These situations do not establish a diagnosis or treatment indication. They may provide a reason to request a structured specialist review of existing records and possible next steps.
Low ovarian reserve
Questions related to ovarian reserve markers and how they should be interpreted within the complete clinical picture.Poor ovarian response
A previous cycle produced a lower response than expected and you would like an additional specialist assessment.Few oocytes retrieved
Previous IVF or ICSI cycles resulted in few retrieved oocytes or limited transferable embryos.Previous unsuccessful IVF
Existing records and prior treatment may benefit from a structured independent review.Advanced reproductive age
You would like realistic counselling about remaining options, limitations and uncertainty.Egg donation discussed
Before deciding, you would like another specialist opinion about the evidence and any remaining appropriate options.Pathway
From orientation to an authorised clinical decision
Initial orientation
Share a concise overview of your question and the records already available. Please use the secure route indicated by the coordination team for identifiable medical information.Specialist clinical review
The authorised medical team assesses the history, diagnostic findings and previous treatment before discussing possible options.Research, when applicable
Research eligibility is assessed separately and only within the approved protocol. Participation is voluntary and does not determine clinical care.No treatment or outcome can be guaranteedSuitability depends on individual clinical assessment. Autologous preparations such as Standard-PRP or IAS may only be considered by the treating team within the applicable clinical and regulatory framework; evidence remains subject to uncertainty.
Scientific context
Understand the distinction between clinical care and observational research
The scientific pages explain the ovarian context and the research pages describe the observational framework without attributing undocumented results.
